Search Results - Wesemeier, Carmen

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Features of extramedullary myeloma relapse: high proliferation, minimal marrow involvement, adverse cytogenetics: a retrospective single-center study of 24 cases

    Features of extramedullary myeloma relapse: high proliferation, minimal marrow involvement, adverse cytogenetics: a retrospective single-center study of 24 cases by Rasche, Leo, Bernard, Corinna, Topp, Max S., Kapp, Markus, Duell, Johannes, Wesemeier, Carmen, Haralambieva, Eugenia, Maeder, Uwe, Einsele, Hermann, Knop, Stefan

    Published in Annals of hematology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Combined functional and molecular analysis of tumor cell signaling defines 2 distinct myeloma subgroups: Akt-dependent and Akt-independent multiple myeloma

    Combined functional and molecular analysis of tumor cell signaling defines 2 distinct myeloma subgroups: Akt-dependent and Akt-independent multiple myeloma by Zöllinger, Angela, Stühmer, Thorsten, Chatterjee, Manik, Gattenlöhner, Stefan, Haralambieva, Eugenia, Müller-Hermelink, Hans-Konrad, Andrulis, Mindaugas, Greiner, Axel, Wesemeier, Carmen, Rath, Jörg C., Einsele, Hermann, Bargou, Ralf C.

    Published in Blood
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    In vivo monitoring of macrophage infiltration in experimental autoimmune neuritis by magnetic resonance imaging

    In vivo monitoring of macrophage infiltration in experimental autoimmune neuritis by magnetic resonance imaging by Stoll, Guido, Wesemeier, Carmen, Gold, Ralf, Solymosi, Laszlo, Toyka, Klaus V., Bendszus, Martin

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    The Efficacy and Safety of RAD (Lenalidomide, Adriamycin and Dexamethasone) In Newly Diagnosed Multiple Myeloma – First Results of a Phase II Trial by the German DSMM Group

    The Efficacy and Safety of RAD (Lenalidomide, Adriamycin and Dexamethasone) In Newly Diagnosed Multiple Myeloma – First Results of a Phase II Trial by the German DSMM Group by Knop, Stefan, Langer, Christian, Engelhardt, Monika, Muegge, Lars O, Reichle, Albrecht, Röllig, Christoph, Gramatzki, Martin, Roesler, Wolf, Topp, Max S, Wesemeier, Carmen, Hertenstein, Bernd, Sturm, Isrid, Dechow, Tobias, Kortüm, Martin, Sauerwein, Marianne, Einsele, Hermann, Bargou, Ralf

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Combined functional and molecular analysis of tumor cell signaling defines 2 distinct myeloma subgroups : Akt-dependent and Akt-independent multiple myeloma. Commentary

    Combined functional and molecular analysis of tumor cell signaling defines 2 distinct myeloma subgroups : Akt-dependent and Akt-independent multiple myeloma. Commentary by LEIF BERGSAGEL, P, ZÖLLINGER, Angela, RATH, Jorg C, EINSELE, Hermann, BARGOU, Ralf C, STÜHMER, Thorsten, CHATTERJEE, Manik, GATTENLÖHNER, Stefan, HARALAMBIEVA, Eugenia, MÜLLER-HERMELINK, Hans-Konrad, ANDRULIS, Mindaugas, GREINER, Axel, WESEMEIER, Carmen

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: